Biosimilars in Rheumatology

May 31, 2019 2:54 pm
  • 1_Jonathan%20Kay.png

    The Promise of Biosimilars
  • 2_Vibeke%20Strand.png

    Characterizing the Reference Product
  • 3_Lee%20Simon.png

    Matching the Reference Product
  • 6_Eric%20Ruderman.png

    Extrapolation of Biosimilars
  • 7_Alvin%20Wells.png

    Clinical Expectations of Biosimilars
  • 8_Xenofon%20Baraliakos.png

    European Experience with Biosimilars
  • 9_Allan%20Gibofsky.png

    What’s Next in Biosimilars

This is a sponsored therapeutic update 

COVID Updates from Rheumnow

Topics

Do you get our email newsletter?

Looking for the latest rheumatology news & trends? Sign up for the RheumNow weekday newsletter:

Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields. Rheumnow.com provides daily updates on the site and in your inbox when you are signed up for our newsletter.

Copyright 2020 All Rights Reserved.

×